Evidence map›Paper›PMID 39443133›Full record

ArticleJournal of atherosclerosis and thrombosis2025

Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China.

Ping-Ting Yang, Li Tang, Hui-Rong Guo, Yong-Mei He, Yue-Xiang Qin, Lei Yan, Zhen-Xin Li, Ya-Zhang Guo, Jian-Gang Wang

Abstract read
In one paragraph

Article in Journal of atherosclerosis and thrombosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. It's Time to Measure Lp(a): Recognizing a Neglected Cardiovascular Risk.Journal of atherosclerosis and thrombosis · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. [Nomogram prediction model for factors associated with vascular plaques in a physical examination population].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ping-Ting YangHealth Management Medical Center, The Third Xiangya Hospital, Central South University.
Li TangShaoxing Second Hospital.
Hui-Rong GuoHealth Management Center, Changji Branch of The First Affiliated Hospital, Xinjiang Medical University.
Yong-Mei HeDepartment of Health Management, Aerospace Center Hospital.
Yue-Xiang QinHealth Management Medical Center, The Third Xiangya Hospital, Central South University.
Lei YanDepartment of General Practice CThe Third Xiangya Hospital, Central South University.
Zhen-Xin LiXiangya School of Medicine, Central South University.
Ya-Zhang GuoHealth Management Center, First Affiliated Hospital of Jishou University.
Jian-Gang WangHealth Management Medical Center, The Third Xiangya Hospital, Central South University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsLipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and its level is genetically determined. Although guidelines and consensuses in various cardiovascular fields have emphasized the importance of Lp(a), screening for Lp(a) in China has not been well studied.

methodsA cross-sectional study was conducted using a random sample of 30,000 medical examiners from each of the five health check-up centres. The distribution of Lp(a) was described for those who completed Lp(a) testing, and logistic regression modelling was used to evaluate the relationship between Lp(a) levels and vascular structure and function in the population who underwent carotid ultrasound and brachial‒ankle pulse wave velocity (baPWV) measurements.

resultsLp(a) was measured in only 4400 (3.02%) of the 150,000 participants. Among those tested for Lp(a), the median concentration was 15.85 mg/dL. The proportion of participants with Lp(a) levels ≥ 30 mg/dL was 15.00%. Multiple logistic regression analysis revealed a significant correlation between Lp(a) and cIMT ≥ 1.0 mm (OR: 1.008, 95% CI: 1.001-1.014, P=0.020) and carotid artery plaques (OR: 1.010, 95% CI: 1.004-1.016, P=0.001) but no correlation with baPWV ≥ 1400 (OR: 0.999, 95% CI: 0.993-1.005, P=0.788) or baPWV ≥ 1800 (OR: 1.002, 95% CI: 0.993-1.011, P=0.634).

conclusionsThe detection rate of Lp(a) at health checkups is low, and Lp(a) is positively associated with cervical vascular sclerosis and plaque but not with baPWV. Therefore, the testing rate of Lp(a) and the awareness of the risk of vascular structural changes due to Lp(a) should be further improved.

Indexed as

ArteriosclerosisBiomarkersLipoprotein(a)AdultAgedAnkle Brachial IndexAsymptomatic DiseasesCarotid Intima-Media ThicknessChinaCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalencePrognosisBiomarkersLipoprotein(a)AtherosclerosisBrachial-ankle pulse wave velocity (baPWV)Carotid intima-media thickness (cIMT)Lipoprotein(a)Testing rate

Identifiers

PMID39443133
PMCPMC11973526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.